STTK vs. BDTX

Last updated Jun 4, 2026

STTK (Shattuck Labs, Inc.) and BDTX (Black Diamond Therapeutics, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, STTK returned -30.36%/yr vs -30.24%/yr for BDTX. At a 0.25 correlation, their price movements are largely independent.

Performance

STTK vs. BDTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Shattuck Labs, Inc. (STTK) and Black Diamond Therapeutics, Inc. (BDTX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, STTK achieves a 30.14% return, which is significantly higher than BDTX's -13.58% return.

STTK

• 1D: -2.46%
• 1M: -31.36%
• YTD: 30.14%
• 6M: 82.69%
• 1Y: 365.69%
• 3Y*: 18.84%
• 5Y*: -30.36%
• 10Y*: —

BDTX

• 1D: -3.67%
• 1M: -22.22%
• YTD: -13.58%
• 6M: -21.93%
• 1Y: -16.00%
• 3Y*: -3.54%
• 5Y*: -30.24%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

STTK vs. BDTX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
STTK Shattuck Labs, Inc.	30.14%	201.65%	-83.03%	210.00%	-72.97%	-83.76%	170.85%
BDTX Black Diamond Therapeutics, Inc.	-13.58%	13.55%	-23.84%	56.11%	-66.23%	-83.37%	-5.12%

Correlation

The correlation between STTK and BDTX is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.27
Correlation (3Y) Calculated over the trailing 3-year period	0.24
Correlation (5Y) Calculated over the trailing 5-year period	0.26
Correlation (All Time) Calculated using the full available price history since Oct 12, 2020	0.25

Fundamentals

Market Cap STTK : $533.11M BDTX : $120.19M
EPS STTK : -$0.59 BDTX : -$0.76
PB Ratio STTK : 5.56 BDTX : 1.15
Total Revenue (TTM) STTK : $1.00M BDTX : $0.00
Gross Profit (TTM) STTK : -$835.00K BDTX : -$152.00K
EBITDA (TTM) STTK : -$48.60M BDTX : -$40.34M

Return for Risk

STTK vs. BDTX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

STTK

STTK Risk / Return Rank: 94
STTK Sharpe Ratio Rank: 97
STTK Sortino Ratio Rank: 93
STTK Omega Ratio Rank: 91
STTK Calmar Ratio Rank: 97
STTK Martin Ratio Rank: 95

BDTX

BDTX Risk / Return Rank: 35
BDTX Sharpe Ratio Rank: 33
BDTX Sortino Ratio Rank: 37
BDTX Omega Ratio Rank: 38
BDTX Calmar Ratio Rank: 32
BDTX Martin Ratio Rank: 33

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

STTK vs. BDTX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Shattuck Labs, Inc. (STTK) and Black Diamond Therapeutics, Inc. (BDTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	STTK	BDTX	Difference
Sharpe ratio: Return per unit of total volatility	3.67	-0.19	+3.86
Sortino ratio: Return per unit of downside risk	3.72	0.32	+3.40
Omega ratio: Gain probability vs. loss probability	1.45	1.04	+0.41
Calmar ratio: Return relative to maximum drawdown	9.28	-0.28	+9.55
Martin ratio: Return relative to average drawdown	19.92	-0.46	+20.38
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

STTK vs. BDTX - Sharpe Ratio Comparison

The current STTK Sharpe Ratio is 3.67, which is higher than the BDTX Sharpe Ratio of -0.19. The chart below compares the historical Sharpe Ratios of STTK and BDTX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	STTK	BDTX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	3.67	-0.19	+3.86
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.26	-0.23	-0.03
Sharpe Ratio (All Time) Calculated using the full available price history	-0.19	-0.30	+0.11

Drawdowns

STTK vs. BDTX - Drawdown Comparison

The maximum STTK drawdown since its inception was -98.73%, roughly equal to the maximum BDTX drawdown of -97.21%. Use the drawdown chart below to compare losses from any high point for STTK and BDTX.

Drawdown Indicators

	STTK	BDTX	Difference
Max Drawdown Largest peak-to-trough decline	-98.73%	-97.21%	-1.52%
Max Drawdown (1Y) Largest decline over 1 year	-39.72%	-58.32%	+18.60%
Max Drawdown (3Y) Largest decline over 3 years	-93.45%	-83.09%	-10.36%
Max Drawdown (5Y) Largest decline over 5 years	-97.59%	-90.50%	-7.09%
Current Drawdown Current decline from peak	-91.75%	-95.31%	+3.56%
Average Drawdown Average peak-to-trough decline	-83.06%	-78.59%	-4.47%
Ulcer Index Depth and duration of drawdowns from previous peaks	18.46%	34.94%	-16.48%

Volatility

STTK vs. BDTX - Volatility Comparison

The current volatility for Shattuck Labs, Inc. (STTK) is 23.12%, while Black Diamond Therapeutics, Inc. (BDTX) has a volatility of 53.78%. This indicates that STTK experiences smaller price fluctuations and is considered to be less risky than BDTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	STTK	BDTX	Difference
Volatility (1M) Calculated over the trailing 1-month period	23.12%	53.78%	-30.66%
Volatility (6M) Calculated over the trailing 6-month period	51.52%	72.08%	-20.56%
Volatility (1Y) Calculated over the trailing 1-year period	100.61%	83.87%	+16.74%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	117.35%	132.74%	-15.39%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	114.28%	124.05%	-9.77%

Dividends

STTK vs. BDTX - Dividend Comparison

Neither STTK nor BDTX has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both STTK and BDTX in my portfolio?

STTK and BDTX have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, STTK or BDTX?

BDTX has higher volatility (53.78%) compared to STTK (23.12%). In terms of maximum drawdown, STTK dropped -98.73% vs BDTX's -97.21%.

Which has better risk-adjusted returns?

STTK currently has the higher Sharpe Ratio (3.67 vs -0.19), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.